The developments in the laboratory of Woo Suk Hwang of SeoulNational University in South Korea are profoundly disappointingto all scientists — not solely stem-cell biologists, althoughwe are the most immediately affected and will be subjected tothe greatest scrutiny. It would be an overreaction, however,to attach apocalyptic significance to this incident either forthe stem-cell field or for biomedical research in general. Althoughthe events of Hwang's story provide a case study of some ofthe worst aspects of high-profile, high-stakes global science,they also include some reassuring elements.
Dr. Snyder is the program director and a professor, and Dr. Loring an associate professor and director of the Stem-Cell Resource in the Program in Stem Cells and Regeneration (Developmental and Regenerative Cell Biology), Burnham Institute for Medical Research, La Jolla, Calif.
An interview with Dr. Snyder can be heard at www.nejm.org.
This article has been cited by other articles:
Baylis, F, McLeod, C
(2007). The stem cell debate continues: the buying and selling of eggs for research. J. Med. Ethics
33: 726-731
[Full Text]
Brown, J. K., Ewart, G., Hogan, B. L. M., Neubauer, J., Randell, S. H., Stripp, B., Weiss, D. J.
(2006). Against the ATS Statement on Human Embryonic Stem Cell Research. Am. J. Respir. Crit. Care Med.
174: 357a-358
[Full Text]
Sharp, R. R., Yarborough, M.
(2006). Informed Trust and the Financing of Biomedical Research. J Law Med Ethics
34: 460-464
Van Way, C. W. III
(2006). The Vulnerability of Biomedical Science. JPEN J Parenter Enteral Nutr
30: 266-267
[Full Text]
Interview
